Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...

HTX Research, the dedicated research arm of HTX, has released its Q3 2026 outlook report, Liquidity Defines Crypto: A New ...

Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

The absolute risk appears low, but new data suggest small changes in smell and taste with GLP-1 treatment may exceed those already associated with type 2 diabetes.

Wild greater honeyguide birds in sub-Saharan Africa have learned to recognize specific human vocal calls used by local ...

Objective While guidelines advocate renin-angiotensin system inhibitors (RASi) for renoprotection in lupus nephritis (LN), ...

The old paradigm of software in ag equipment was that software was used to enable your machine. That paradigm is dead. The ...

IGSB ETF analysis: short/intermediate IG credit, 2.7-year duration and spread risks in a higher-for-longer Fed regime.

16 AI trading tools transform raw market data into actionable strategies, from Claude-generated Pine Script to real-time news ...